India develops nasal COVID vaccine

In a significant development, Bharat Biotech has sought Drug Controller General India’s (DCGI) approval to conduct nasal COVID-19 vaccine trials in India. The company has developed a new single-dose nasal COVID-19 vaccine in a partnership with Washington University in St Louis, USA. There are no intra-nasal COVID-19 vaccines under trial in India at the moment. […]

The post India develops nasal COVID vaccine appeared first on Blitz.

[Read More]

—–
Source: Weekly Blitz :: Writings


« Previous Post
Next Post »
 

Comments are closed. Please check back later.

 
 
 
1